Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor
- 1 March 1993
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 69 (5), 443-452
- https://doi.org/10.1016/0049-3848(93)90233-e
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulationThrombosis Research, 1991
- Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgeryThrombosis Research, 1991
- Anti-Xa clotting activities in different hepatic-triglyceride lipase preparations from post-heparin plasmaThrombosis Research, 1991
- Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPIThrombosis Research, 1991
- Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)Thrombosis Research, 1988
- Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosisBritish Journal of Surgery, 1988
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Spectroelectrochemical study of the cytochrome a site in carbon monoxide-inhibited cytochrome c oxidaseBiochemistry, 1986
- Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administrationThrombosis Research, 1985
- A Brain Extract as a Substitute for Platelet Suspensions in the Thromboplastin Generation TestNature, 1954